View Press Releases
-
ZeOmega Reports Record Demand and Growth for PHM Solution in 2022
New and Expanded Agreements with Major Healthcare Organizations Underscore ZeOmega as Go-to Resource for Population Health Management
Jan 30, 2023
-
TC Biopharm adds Bree Harlin as Chief Clinical Officer to Lead Global Clinical Division
Former Loxo@Lily exec Bree Harlin has been appointed CCO by TC BioPharm to oversee expansion of U.S. FDA clinical Trials.
Jan 29, 2023
-
Verisense Health, a Shimmer Research Spin-off, Launches as a Digital Health Software and Data Management Company
Verisense® Health, Inc. launched today as a digital health software and data management company. It was established with the goal of providing sponsors with cost-efficient access to a digital biobank of longitudinal raw patient data. The new company is a spin-off from Dublin-based wearable technology services and sensor manufacturer Shimmer Research.
Jan 29, 2023
-
Creative Proteomics Revised Its Molecular-Interaction Subsite for a Better User Experience
-
Creative Proteomics Lipidomics Upgrades Its Medium-Chain and Long-Chain Fatty Acids Analysis Service
-
Creative Proteomics Metabolomics Expands Service Offering with the Launch of Gut Microbiota Metabolomics Solution
-
Exosome Research—Impeding into an Epoch of Bursting Development
A recent market report reveals the huge potential of exosome research, which is gaining mounting research fever across the industry.
Jan 29, 2023
-
CD BioGlyco Developed Various Strategies for Sialic Acid Analysis
-
Creative Biostructure Provides iEM Platform for Viral Research
-
MicrobioSeq’s Plasmid Identification Service Boosts Microbial Characterization Research
-
CD Genomics Optimized Cancer Hotspot Panel Sequencing Service for Cancer-Related Research
-
CD Genomics Introduces Professional and Mature Long Amplicon Analysis Service
-
Huateng Pharma Supplies CAS NO.864731-61-3 in Large Quantities
About Huateng Pharma Huateng Pharma is a leading and professional manufacturer which can provide APIs, pharmaceutical intermediates, PEG derivatives, biochemical reagents, Vitamin D Derivatives and so on. We have established a 5000 square meters R&D center and have our own manufacturing site covering 34,000 square meters. Contact us Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818
Jan 27, 2023
-
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results
-
iVexSol Closes $23.8M Series A-3 Financing; Funds to Revolutionize the Production of Lentiviral Vectors
-
Kroger Health Establishes Clinical Trial Site Network to Increase Reach and Access to Research Studies
Announcement comes with the collaboration with biopharmaceutical industry to introduce colorectal cancer clinical trial
Jan 24, 2023
-
Beacon Biosignals CEO Jacob Donoghue to Speak On Panel at Precision Medicine World Conference
Beacon Biosignals CEO Jacob Donoghue to Speak On Panel at Precision Medicine World Conference
Jan 23, 2023
-
Curebase Launches All-in-One Software and Trial Execution Package to Help Digital Therapeutics Companies Accelerate Clinical Trials
Curebase Launches All-in-One Software and Trial Execution Package to Help Digital Therapeutics Companies Accelerate Clinical Trials
Jan 23, 2023
-
Bellin Health Drives Increase in Online Self-Scheduling Appointments with Launch of New Patient Access Experience from Kyruus
Kyruus today announced that integrated healthcare delivery system, Bellin Health, recently selected Kyruus to support a new digital patient access experience on its website.
Jan 23, 2023
-
Linus Health Earns Numerous Awards as Digital Health Pioneer in Alzheimer’s and Other Dementia
Recent accolades honoring the company’s technology and workplace reflect its growing industry impact
Jan 23, 2023